Sichenzia Ross Steers Calif. Biopharma Firm On $20M IPO
Oncology-focused biopharmaceutical firm INmune Bio Inc. on Wednesday said it intends to raise up to $20 million from an initial public offering guided by Sichenzia Ross Ference LLP, as it looks...To view the full article, register now.
Already a subscriber? Click here to view full article